Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrix

Journal of Immunology

Volumn 173, Issue 9, 2004, Pages 5458-5466

  Baratelli, Felicita E ^a   Heuzé Vourc'h, Nathalie ^a   Krysan, Kostyantyn ^a   Dohadwala, Mariam ^a   Riedl, Karen ^a   Sharma, Sherven ^a   Dubinett, Steven M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; E PROSTANOID RECEPTOR 2; GELATINASE B; MATRIX METALLOPROTEINASE; NEUTRALIZING ANTIBODY; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; RECOMBINANT ENZYME; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; 16,16 DIMETHYLPROSTAGLANDIN E2; CC CHEMOKINE RECEPTOR 7; CHEMOKINE RECEPTOR; IMMUNOLOGICAL ADJUVANT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN EP2 RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL MIGRATION; DENDRITIC CELL; ENZYME INDUCTION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG CANCER; MONOCYTE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; SUPERNATANT; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; ENZYMOLOGY; GENETIC TRANSFECTION; IMMUNOLOGY; LEUKOCYTE MIGRATION INHIBITION TEST; METABOLISM; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

16,16-DIMETHYLPROSTAGLANDIN E2; ADJUVANTS, IMMUNOLOGIC; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MIGRATION INHIBITION; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASE 9; RECEPTORS, CHEMOKINE; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFECTION; UP-REGULATION;

EID: 6344275644     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.9.5458     Document Type: Article

References (60)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
3. Cyster, J. G. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286:2098.
4. Dieu-Nosjean, M. C., A. Vicari, S. Lebecque, and C. Caux. 1999. Regulation of dendritic cell trafficking: a process that involves the participation of selective Chemokines. J. Leukocyte Biol. 66:252.
5. Caux, C., S. Ait-Yahia, K. Chemin, O. de Bouteiller, M. C. Dieu-Nosjean, B. Homey, C. Massacrier, B. Vanbervliet, A. Zlotnik, and A. Vicari. 2000. Dendritic cell biology and regulation of dendritic cell trafficking by Chemokines. Springer Semin. Immunopathol. 22:345.
6. Sozzani, S., P. Allavena, A. Vecchi, and A. Mantovani. 1999. The role of chemokines in the regulation of dendritic cell trafficking. J. Leukocyte Biol. 66:1.
7. Brown, P. D., and R. Giavazzi. 1995. Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann. Oncol. 6:967.
8. Faveeuw, C., G. Preece, and A. Ager. 2001. Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 98:688.
9. Vu, T. H., and Z. Werb. 2000. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14:2123.
10. Emonard, H., and J. A. Grimaud. 1990. Matrix metalloproteinases: a review. Cell. Mol. Biol. 36:131.
11. Timpl, R. 1989. Structure and biological activity of basement membrane proteins. Em. J. Biochem. 180:487.
12. Brew, K., D. Dinakarpandian, and H. Nagase. 2000. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477:267.
13. Nagase, H., and J. F. Woessner, Jr. 1999. Matrix metalloproteinases. J. Biol. Chem. 274:21491.
14. Bartholome, E. J., I. Van Aelst, E. Koyen, R. Kiss, F. Willems, M. Goldman, and G. Opdenakker. 2001. Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-β. J. Interferon Cytokine Res. 21:495.
15. Kouwenhoven, M., V. Ozenci, A. Tjernlund, M. Pashenkov, M. Homman, R. Press, and H. Link. 2002. Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis. J. Neuroinmunol. 126:161.
16. Osman, M., M. Tortorella, M. Londei, and S. Quaratino. 2002. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived dendritic cells. Immunology 105:73.
17. Kobayashi, Y., M. Matsumoto, M. Kotani, and T. Makino. 1999. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J. Immunol. 163:5989.
18. Hollender, P., D. Ittelet, F. Villard, J. C. Eymard, P. Jeannesson, and J. Bernarrd. 2002. Active matrix metalloproteinase-9 in and migration pattern of dendritic cells matured in clinical grade culture conditions. Immunobiology 206:441.
19. Borden, P., and R. A. Heller. 1997. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit. Rev. Eukaryotic Gene Expression 7:159.
20. + cells and their transmigration through reconstituted basement membrane. Blood 93:3379.
21. Johnatty, R. N., D. D. Taub, S. P. Reeder, S. M. Turcovski-Corrales, D. W. Cottam, T. J. Stephenson, and R. C. Rees. 1997. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J. Immunol. 158:2327.
22. Kossakowska, A. E., D. R. Edwards, C. Prusinkiewicz, M. C. Zhang, D. Guo, S. J. Urbanski, T. Grogan, L. A. Marquez, and A. Janowska-Wieczorek. 1999. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TlMP-1) expression in malignant nonHodgkin's lymphomas. Blood 94:2080.
23. Parks, W. C., and S. D. Shapiro. 2001. Matrix metalloproteinases in lung biology. Respir. Res. 2:10.
24. Zhang, Y., K. McCluskey, K. Fujii, and L. M. Wahl. 1998. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-α, granulocyte-macrophage CSF, and IL-Iβ through prostaglandin-dependent and -independent mechanisms. J. Immunol. 161:3071.
25. 2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J. Immunol. 157:5512.
26. Dannenberg, A. J., and R. N. DuBois. 2003. COX-2 a new target for cancer prevention and treatment. vol. 37. In Progress in Experimental Tumor Research, Karger, Cambridge, Mass.
27. Turini, M. E., and DuBois, R. N. 2002. Cyclooxygenase-2: a therapeutic target. Annu. Rev. Med. 53:35.
28. 2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol. 168:2255.
29. Sharma, S., M. Stolina, S. C. Yang, F. Baratelli, J. F. Lin, K. Atianzar, J. Luo, L. Zhou, Y. Lin, M. Huang, et al. 2003. Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. Clin. Cancer Res. 3:961.
30. Whittaker, D. S., K. S. Bahjat, L. L. Moldawer, and M. J. Clare-Salzler. 2000. Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production. J. Immunol. 165:4298.
31. 2 regulates the migratory capacity of specific DC subsets. Blood 100:1362.
32. 2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100:1354.
33. 2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159:28.
34. 2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161:2723.
35. 2 and tumor necrosis factor α cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med. 186:1603.
36. Tilley, S. L., T. M. Coffman, and B. H. Koller. 2001. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108:15.
37. Breyer, R. M., C. K. Bagdassarian, S. A. Myers, and M. D. Breyer. 2001. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41:661.
38. 2 produiction by nonsmall cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclopxygenase-2-dependent invasion. J. Biol. Chem. 277:50828.
39. Masure, S., A. Billiau, J. Van Damme, and G. Opdenakker. 1990. Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate. Biochim. Biophys. Acta 1054:317.
40. 2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276:18075.
41. Dohadwala, M., J. Luo, L. Zhou, Y. Lin, G. Dougherty, S. Sharma, M. Huang, M. Pold, R. K. Batra, and S. M. Dubinett. 2001. Non-small cell lung cancer cyclooxygenase-2 dependent invasion is mediated by CD44. J. Biol. Chem. 276:20809.
42. Ratzinger, G., P. Stoitzner, S. Ebner, M. B. Lutz, G. T. Layton, C. Rainer, R. M. Senior, J. M. Shipley, P. Fritsch, G. Schuler, and N. Romani. 2002. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J. Immunol. 168:4361.
43. Bodden, M. K., G. J. Harber, B. Birkedal-Hansen, L. J. Windsor, N. C. M. Caterina, J. A. Angler, and H. Birkedal-Hansen. 1994. Functional domains of human TIMP-1 (tissue inhibitor of metailoproteinases). J. Biol. Chem. 269:18943.
44. Abramovitz, M., M. Adam, Y. Boie, M. Carriere, D. Denis, C. Godbout, S. Lamontagne, C. Rochelte, N. Sawyer, N. M. Tremblay, et al. 2000. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta 1483:285.
45. Huang, M., M. Stolina, S. Sharma, J. T. Mao, L. Zhu, P. W. Miller, J. Wollman, H. Herschman, and S. M. Dubinett. 1998. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res. 58:1208.
46. Liu, C. M., C. Y. Hong, C. T. Shun, J. S. Wang, T. Y. Hsiao, C. C. Wang, and S. K. Lin. 2001. Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expressions and their differential regulation by proinflammatory cytokines and prostaglandin in nasal polyp fibroblasts. Ann. Otol. Rhinol. Laryngol. 110:1129.
47. 2 on recombinant equine interleukin-1β-stimulated matrix metalloproteinases 1,3,and 13 and tissue inhibitor of matrix metalloproteinase 1 expression in equine chondrocyte cultures. Am. J. Vet. Res. 63:987.
48. 4 receptor subtypes. J. Leukocyte Biol. 73:756.
49. 4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9:744.
50. 2 receptor. Biochemistry 35:7159.
51. Harris, S. R., J. Padilla, L. Koumas, D. Ray, and R. P. Phipps. 2002. Prostaglandins as modulator of immunity. Trends Immunol. 23:144.
52. 2 receptor. J. Clin. Invest. 111:727.
53. Matsumoto-Taniura, N., K. Matsumoto, and T. Nakamura. 1999. Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts. Br. J. Cancer 81:194.
54. Rozic, J. G., C. Chakraborty, and P. K. Lala. 2001. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int. J. Cancer. 93:497.
55. Bell, D., P. Chomarat, D. Broyles, G. Netto, G. M. Harb, S. Lebecque, J. Valladeau, J. Davoust, K. A. Palucka, and J. Banchereau. 1999. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med. 190:1417.
56. Paoletti, P., C. Chiabrando, P. Gaetani, M. G. Castelli, G. Butti, L. Martelli, and M. Rolli. 1989. Prostaglandins in human brain tumors. J. Neurosurg. Sci. 33:65.
57. 2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor I. 2003. J. Immunol. 171:3936.
58. 2 affects maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J. Immunol. 170:4943.
59. Opdenakker, G., P. E. Van den Steen, and J. Van Damme. 2001. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol 22:571.
60. Rhee, J. S., R. Diaz, L. Korets, J. G. Hodgson, and L. M. Coussens. 2004. TIMP-1 alters susceptibility to carcinogenesis. Cancer Res. 64:952.